Agree - I read that they want to get into the market fast with low cost whilst the phos prices are crazy high with phase 1.5, total spend on project remains the same or lower due to improvements discovered during commissioning and current running. Good news story. Later on they ramp up to 800kt. I wonder if they even need to run at 800kt if they will be printing money at 600kt at these prices. Use that capital for other acquisitions and growth instead.
- Forums
- ASX - By Stock
- CXM
- New Broker Research
CXM
centrex limited
Add to My Watchlist
0.00%
!
1.7¢

New Broker Research, page-118
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.74M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CXM (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online